
Natera NTRA
€ 172.72
0.35%
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Natera Langfristiger Schuldenstrom 2011-2026 | NTRA
Langfristiger Schuldenstrom Jährlich Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.64 M | 5.75 M | 7.3 M | 5.74 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.64 M | 5.74 M | 6.61 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
3.3 M | $ 8.99 | 1.35 % | $ 599 M | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 13.73 | 0.59 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 25.9 | 0.27 % | $ 719 M | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
21.6 M | $ 67.32 | 1.48 % | $ 26.3 B | ||
|
Guardant Health
GH
|
27.7 M | $ 88.75 | 1.8 % | $ 11.1 B | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 153.71 | 1.14 % | $ 7.62 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 17.6 | 1.62 % | $ 938 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | $ 103.94 | 0.09 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 15.43 | 3.21 % | $ 467 M | ||
|
Biodesix
BDSX
|
719 K | $ 16.59 | -4.05 % | $ 2.15 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 100.49 | 2.95 % | $ 8.29 B | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.89 | 1.76 % | $ 93.8 K | ||
|
IQVIA Holdings
IQV
|
93 M | $ 168.43 | 2.15 % | $ 29 B | ||
|
Danaher Corporation
DHR
|
199 M | $ 195.21 | 2.0 % | $ 139 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
448 K | $ 1.38 | 1.47 % | $ 414 M | ||
|
Illumina
ILMN
|
79 M | $ 120.84 | 1.31 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 198.61 | -0.17 % | $ 22 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.13 | 1.8 % | $ 1.44 M | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 8.75 | 3.92 % | $ 248 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.27 | 0.36 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.27 | 1.76 % | $ 2.01 B | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 80.45 | 2.48 % | $ 5.43 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
838 K | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 455.15 | 0.33 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 206.72 | 0.63 % | $ 24.9 B | ||
|
Celcuity
CELC
|
172 K | $ 114.11 | -0.69 % | $ 4.5 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
451 K | $ 17.73 | 1.9 % | $ 397 M | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 47.28 | 5.04 % | $ 2.83 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K |